Original language | English (US) |
---|---|
Pages (from-to) | E234933 |
Journal | JAMA ophthalmology |
Volume | 142 |
Issue number | 5 |
DOIs |
|
State | Published - May 16 2024 |
Funding
Conflict of Interest Disclosures: Dr Marchese reported receiving personal fees from Kilabs Pharma. Dr Gill reported receiving grants from Research to Prevent Blindness and consultant fees from Genentech-Roche and Regeneron. No other disclosures were reported.
ASJC Scopus subject areas
- Ophthalmology